Oxford Coronavirus vaccine seems to produce an immune response in people over 55.
The University of Oxford created a viable coronavirus vaccine which has been used to treat older infected candidate.
The results are impressive and the candidates immune responded rapidly.
READ ALSO | #EndSARS; Fashola Finds A Camera At Lekki Tollgate.
Older people are at an increased risk of becoming severely ill and dying from covid-19, partly because the immune system weakens the age.
The finding, which has not yet been published, builds on results from July which found that the vaccine also produces an immune response in younger adults, aged between 18 and 55.
The vaccine candidate is being developed by pharmaceutical company AstraZeneca in partnership with the University of Oxford.
An AstraZeneca spokesperson told CNBC today, “It is encouraging to see immunogenicity responses were similar between older and younger adults,”
Matt Hancock, UK health minister today said the government was preparing to roll out a coronavirus vaccine and expects it will be ready in the first half of 2021.
Hancock also said that he doesn’t rule out the possibility that some people could receive a vaccine this year.
Yesterday, US health adviser Anthony Fauci said it should be known by the end of November or early December if a coronavirus vaccine candidate was safe and effective.
Fauci, speaking on the BBC’s Andrew Marr Show, added: “The question is, once you have a safe and effective vaccine, or more than one, how can you get it to the people who need it as quickly as possible?”